Skip to content

Mixed Phenotype Acute Leukemia T Myeloid Cn372142

Published: July 22, 2026Updated: August 20, 2026

A hybrid blood cancer with T-cell and myeloid features, affecting children and adults. Treatment includes intensive chemotherapy and stem cell transplant, with serious prognosis.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Severe headache

Fatigue

(hematologic)

Mucosal bleeding

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Acute lymphoblastic leukemia-style chemotherapy

High-intensity multi-drug chemotherapy protocol designed for mixed phenotype acute leukemia, incorporating steroids, vinca alkaloids, and anthracyclines to achieve morphological remission.

medication
2

Percutaneous intervention with follow-up

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Consolidation with allogeneic stem cell transplant

Following successful induction, stem cell transplantation from a compatible donor provides potentially curative therapy for this aggressive hematologic malignancy.

procedure

Additional treatment options

Monoclonal antibody therapy

Antibody-based treatments targeting specific cell surface antigens expressed on leukemic blasts may be incorporated into treatment protocols for enhanced disease control.

medication

Minimal residual disease monitoring

Highly sensitive flow cytometry or molecular testing to detect residual leukemia cells below morphological detection threshold, guiding treatment intensity decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Mixed Phenotype Acute Leukemia T Myeloid Cn372142?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2022.

guideline2022
2

Matutes E, Pickl WF, Van't Veer M, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and treatment outcomes. Blood. 2021;137(18):2461-2470.

review2021
3

Hrusak O, de Haas V, Stancikova J, et al. International cooperative study identifies treatment strategy for childhood mixed phenotype acute leukemia. J Clin Oncol. 2019;37(12):994-1006.

clinical_trial2019
4

Weinberg OK, Arber DA. Mixed phenotype acute leukemia: a historical perspective and contemporary approach to diagnosis. Haematologica. 2020;105(7):1812-1822.

review2020

Medication Comparisons

Compare medications used to treat Mixed Phenotype Acute Leukemia T Myeloid Cn372142. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy